PeriGen Proves It
by Matthew Sappern, Chief Executive Officer
Hello PeriGen family and friends. I hope you enjoy this issue of PeriNews. Please feel free to let us know what you like and what you don’t.
As CEO of PeriGen, I have the pleasure to work with and address a number of organizations focused on continuously improving healthcare information technology. It’s a passion of mine – I truly believe in the synergy of IT and clinical practice. To that point, I have been asked to participate as a presenter in an upcoming healthcare innovation conference in Nashville entitled Health:Further. It’s a most fitting title for PeriGen representation because we lead the industry in bringing the power of data analytics and visualization to the bedside.
The panel in which I am participating is entitled “Prove It!” which is THE great challenge for most companies striving to innovate. Fortunately, PeriGen’s technology IS proven, starting with its foundation of accurately interpreting fetal strips in real-time. PeriGen’s ability is definitively shown in a published NICHD study showing remarkable rates of agreement (>90%) between the PeriGen system and multiple clinicians. Not perfect by any stretch, but certainly VERY reliable. That alone is a novel and valuable building block, but what’s more impressive and innovative is how health systems operationalize this capability.
One such example is MedStar and its oxytocin management policies which became more manageable, more consistent, and therefore more impactful after the introduction of automation supporting clinical decisions. Combining straightforward procedure with the ability to identify concerning contraction patterns in real-time, the excellent staff at MedStar reduced the incidence and duration of uterine tachysystole in its patients receiving oxytocin by close to 40%.
We’ve taken this recipe for success to a new level with the newly introduced PeriCALM® CheckList™. This tool can be configured to look for any number of concerning EFM patterns together or discretely and alert clinical staff immediately and with great detail. Among other uses, clients are configuring this tool to automate the vigilant monitoring of EFM patterns used in comprehensive OB checklists, such as those employed by nurses when administering oxytocin. EFM-related tasks which require complex and repetitive human calculations will be aided by the PeriCALM Checklist.
We are excited to introduce this innovation and thrilled by its reception in demonstrations, both personal and those at this year’s AWHONN Convention. More than that, we are looking forward to working with you to operationalize the new technology, improve care and to “Prove It!” to the rest of the world.
